Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery Infarct

Middle Cerebral Artery Infarction Clinical Trial

Official title:
An Open Lable, Phase II Exploratory Study Assessing the Efficacy of Intravenous Autologous Mesenchymal Stem Cells in Patients With Middle Cerebral Artery Infarct

Status Recruiting

Clinical Trial Summary

This study aims to determine the efficacy of intravenous transplantation of autologous bone marrow-derived mesenchymal stem cells in patients with acute middle cerebral artery infarct.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Infarction, Middle Cerebral Artery
Middle Cerebral Artery Infarction

Clinical Trial Details

NCT number	NCT01461720
Study type	Interventional
Source	National University of Malaysia
Contact	Norlinah Mohamed Ibrahim, MD
Email	norlinah@ppukm.ukm.edu.my, norlinah@gmail.com
Status	Recruiting
Phase	Phase 2
Start date	March 2012
Completion date	March 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00950521` - Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients	Phase 2
Completed	`NCT00612300` - Gait Training for Persons With Stroke	Phase 0
Completed	`NCT02425670` - Stem Cell Therapy For Acute Ischemic Stroke Patients	Phase 2
Terminated	`NCT02609256` - Stereotactic Infarct Tissue Aspiration for Malignant Infarction of Middle Cerebral Artery	N/A